Herbal 'health' products: What family physicians need to know

American Family Physician

Volumn 58, Issue 5, 1998, Pages 1133-1140

  Zink, Therese ^a   Chaffin, Jodi ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b HEALTHPARTNERS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRINE; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; NATURAL PRODUCT;

ARTICLE; CEREBROVASCULAR ACCIDENT; DEPRESSION; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; DRUG USE; ECHINACEA; GARLIC; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; MIGRAINE; SELF MEDICATION; TANACETUM PARTHENIUM;

FAMILY PRACTICE; HUMANS; PATIENT EDUCATION; PLANTS, MEDICINAL; UNITED STATES;

EID: 0032191390     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Brevoort P. Overview of the U.S. botanical market. Third Conference on Botanicals. Washington, D.C.: Drug Information Association, January 27-28, 1997.
2. Eliason BC, Kruger J, Mark D, Rasmann DN. Dietary supplement users: demographics, product use and medical system interaction. J Am Board Fam Pract 1997;10:265-71.
3. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St. John's wort for depression - an overview and meta-analysis of randomised clinical trials. BMJ 1996;313:253-8.
4. St. John's wort. Med Lett Drugs Ther 1997; 39(1014):107-8.
5. Ernst E. St. John's wort, an antidepressant? A systematic, criteria-based review. Phytomedicine 1995;21:67-71.
6. St. John's wort [Monograph]. Santa Cruz, Calif.: American Herbal Pharmacopoeia, 1997.
7. Pharmacist's letter. Stockton, Calif.: Pharmacy Information Services, University of the Pacific School of Pharmacy, 1997.
8. Prescriber's letter. Stockton, Calif.: Therapeutic Research Center, 1997.
9. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992;340:1136-9.
10. Ginkgo. In: Review of natural products [Monograph]. St. Louis, Mo.: Facts and Comparisons, 1994.
11. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997;278:1327-32.
12. Allen J. Extracts from the leaf of Ginkgo biloba. Pharmacist's Letter 1996; document no. 120203.
13. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996;46:1775-6.
14. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997;336:1108.
15. Ginkgo biloba for dementia. Med Lett Drugs Ther 1998;40(1029):63-4.
16. Tyler V. Herbal remedies. J Pharma Technology 1995;11:214-20.
17. Feverfew. In: Review of natural products [Monograph]. St. Louis, Mo: Facts and Comparisons, 1994.
18. Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988;2(8604):189-92.
19. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J [Clin Res] 1985;291(6495):569-73.
20. Pattrick M, Heptinstall S, Doherty M. Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Ann Rheum Dis 1989;48:547-9.
21. HerbalGram. Ma huang update: Ohio amends ephedrine ban. Austin, Tex.: Herbal News, 1997; 39:25.
22. Food and Drug Administration. Dietary supplements containing ephedrine alkaloids: proposed rule. Federal Register June 4, 1997;62(107):30678-724. Retrieved from the World Wide Web 1998: http://frwebgate2.access.gpo.gov/cgi-bin/...
23. Echinacea. In: Review of natural products [Monograph]. St. Louis, Mo: Facts and Comparisons, 1996.
24. HerbalGram. Echinacea: a literature review. Austin, Tex.: Herbal News, 1994;30(Suppl):33-48.
25. German commission E monograph for echinacea purpurea herb. Germany: Special Expert Committee, Federal Health Agency, March 2, 1989.
26. Mayo Clinic Health Letter. Rochester, Minn.: Mayo Foundation for Medical Education and Research, June 1991;9:6.
27. Silagy CA, Neil HA, Lancaster T, Hodgeman J, Vos K, Moore JW, et al. Garlic powder in the treatment of moderate hyperlipidemia: a controlled trial and meta-analysis. J R Coll Physicians Lond 1996; 30:329-34.
28. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol: a meta-analysis. Ann Intern Med 1993;119(7 Pt 1):599-605.
29. Garlic. In: Review of natural products [Monograph]. St. Louis, Mo: Facts and Comparisons, 1994.
30. Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994; 12:463-8.
31. Pierson S. Garlic product organosulfur chemistry, pharmacology and toxicology: an overview for pharmacists. Pharm/alert 1994;2:5:1-9.
32. Berthold HK, Sudhop T, von Bergman K. Effect of a garlic oil preparation on serum lipoprotein and cholesterol metabolism. JAMA 1998;279:1900-2.
33. DeSmet PA. Health risks of herbal remedies. Drug Saf 1995;13:81-93.
34. HerbalGram. Published proposed regulations for good manufacturing practices for dietary supplements. Austin, Tex.: Herbal News 1997;40:24-5.
35. Commission on Dietary Supplement Labels. Report to the President, Congress, and the Secretary of the Department of Health and Human Services. Washington, D.C.: The Commission, 1997.
36. D'Arcy PF. Adverse reactions and interactions with herbal medicines. Part 2 - drug interactions. Adverse Drug React Toxicol Rev 1993;12:147-62.
37. Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997; 127:61-9.